D56.9
Thalassemia, unspecified
Clinical Classification Guidelines
Inclusion Terms
- Mediterranean anemia (with other hemoglobinopathy)
Medical Intelligence & Overview
Thalassemia is a group of inherited blood disorders characterized by the body’s inability to produce adequate hemoglobin, the protein in red blood cells responsible for carrying oxygen throughout the body. When hemoglobin production is disrupted, it results in anemia, which can cause various health issues. Thalassemia is classified as a hemoglobinopathy—a disorder affecting the structure or production of hemoglobin. Specifically, ICD-10 code D56.9 refers to an unspecified form of thalassemia, which may include cases commonly associated with Mediterranean populations. The condition can range from mild to severe and may require ongoing medical care.
Causes & Symptoms
Clinical Causes: Genetic mutations affecting the genes responsible for hemoglobin production Inheritance of defective hemoglobin genes from one or both parents No external environmental factors have been linked directly to the development of thalassemia
Key Symptoms: Persistent fatigue and weakness Pale or jaundiced skin due to anemia Bone deformities, especially in the facial bones and skull Delayed growth and development in children Dark urine or other signs of hemolysis Enlarged spleen and liver Frequent infections due to weakened immune function
Diagnostic & Treatment
Diagnosis Path: Diagnosis typically involves a combination of blood tests such as complete blood count (CBC), hemoglobin electrophoresis, and genetic testing. These tests help determine the type and severity of the anemia. In some cases, a bone marrow examination may be performed to assess red blood cell production. Since D56.9 refers to an unspecified form, further testing can help specify the precise subtype of thalassemia, which influences treatment options.
Treatment Protocols: Management strategies depend on the severity and subtype of the condition. Common approaches include: - Regular blood transfusions to maintain healthy hemoglobin levels - Iron chelation therapy to prevent iron overload caused by frequent transfusions - Folic acid supplements to support red blood cell production - Splenectomy (removal of the spleen) in cases with significant spleen enlargement - Bone marrow or stem cell transplants in severe cases, which may offer a potential cure - Ongoing monitoring and supportive care to address complications Patients with thalassemia often require lifelong medical support, and treatment plans are tailored to meet individual needs.
Clinical Advice & FAQs
Billing Guidance
Is D56.9 a billable ICD-10 code?
Yes, D56.9 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report D56.9?
Clinical documentation must specify the nature of Thalassemia, unspecified and any associated comorbidities for accurate reporting.
Cite this Clinical Reference